Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

"Obesity contributes to worsening heart failure, and while tirzepatide causes considerable weight loss, research is lacking ...

SUMMT has shown for the first time that a drug can reduce major heart failure clinical outcomes in patients with heart ...

Pharmacies that make customized medications are asking the federal Food and Drug Administration to protect their right to ...

Novo Nordisk (NVO) has reportedly launched its popular weight-loss drug Wegovy in China ahead of a rival drug by Eli Lilly ...

CHICAGO -- A long-acting GIP/GLP-1 receptor agonist conferred significant clinical benefit for people with obesity and ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out drugs are emerging.

HF specialists agree these drugs will be key tools in fighting the obesity-related HFpEF epidemic. Hurdles and questions ...

But the agency said later it was re-evaluating the decision that the shortage is over amid litigation, putting compounding of ...

The study examined GLP-1 drugs, which include semaglutide and tirzepatide. Semaglutide is a key ingredient in Ozempic and Wegovy. Wegovy and Ozempic have also been found to reduce other risks ...

But the agency said later it was re-evaluating the decision that the shortage is over amid litigation, putting compounding of tirzepatide into a gray area. Meanwhile, semaglutide remains on the ...